Form 4 for AGL agilon health, inc.
Accepted 2026-04-03 19:36:38 ET · period of report 2026-04-01 · accession 0001628280-26-023762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-03 19:36 | 2026-04-01 | AGL | Zamore Denise | CLO | F - Tax | $9.75 | -1,024 | 16.8K | -6% | -$9,984 | |
| 2026-04-03 19:36 | 2026-04-01 | AGL | Zamore Denise | CLO | A - Grant | $0.00 | +50.0K | 66.8K | +297% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | F | D | 1,024 | $9.75 | 16,837 | D | — | — | (F1) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. (F2) The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. |
| 2 | Common | Common Stock | 2026-04-01 | A | A | 50,000 | $0.00 | 66,837 | D | — | — | (F3) Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment. (F4) Includes restricted stock units. |